STRENGTH Results May Weaken Chances For Omega-3 Fatty Acid Heart Health Claims
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.
You may also be interested in...
AF events occurred in 469 (3.7%) of subjects receiving EPA and DHA supplements compared to 431 (3.4%) of participants receiving placebos. In vitamin D3 and placebo comparison, AF events occurred in 469 (3.7%) versus 431 (3.4%).
FDA intends to exercise enforcement discretion regarding QHCs about the association between reduced risk of recurrent UTI and use of supplements with at least 500 mg cranberry fruit powder and of cranberry juice beverages containing at least 27% cranberry juice.
Omega-3 supplementation results in 8% reduction in heart attack and coronary heart disease risk over a five-year period versus placebo, finds a meta-analysis in JAMA. Encompassing 120,000 patients, research updates recent meta-analyses with addition of three studies in past year, two casting doubt on heart health benefits of omega-3s.